Semaglutide is associated with nonarteritic anterior ischemic optic neuropathy (NAION) among patients with type 2 diabetes (T2D) and those with overweight/obesity.

Half of the websites (49.4%) failed to mention risks including adverse effects, warnings and precautions, and ...

A new analysis finds nearly half of the compounded GLP-1 websites didn’t include information on adverse effects, warnings, ...

Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.

2-Year U.S. Treasury Note Continuous Contract $102.797-0.008-0.01% 5-Year U.S. Treasury Note Continuous Contract $106.227-0.039-0.04% 10-Year U.S. Treasury Note Continuous Contract $108.547-0.063 ...

Drug delivery describes the method and approach to delivering drugs or pharmaceuticals and other xenobiotics to their site of action within an organism, with the goal of achieving a therapeutic ...